Welcome.
Post-doctoral research fellow,
2007-present
Division of Gastroenterology and Hepatology
Stanford
University's School of Medicine
PI: Jeffrey Glenn, Ph.D., M.D.,
Director, Center of Hepatitis and Liver Tissue Engineering
Ph.D. in Chemical
Engineering, 2003-2006
M.S. in Material Science and Engineering,
2001-2003
Stanford University
Advisor: Curtis W. Frank,
Ph.D., Director, Center for Polymer Interfaces and Macromolecular Assemblies;
Senior Associate Dean, Faculty Affairs
My CV in
PDF
News update!
Contact
Nam-Joon Cho (ncho at
stanford.edu)
CCSR Bldg. Rm 3110, 269 Campus Dr. Stanford, CA 94305
Nam-Joon Cho's



My paper on a novel class of HCV inhibitors was accepted in
Science Translational Medicine in January 2010.
Articles
highlighting this work as of January 25th, 2010:
Reuters, Team finds potential path for Hepatitis C drugs
CNBC, Team finds potential path
for Hepatitis C drugs
BusinessWeek,
New treatment
eyed for Hepatitis C
Agence
France Presse, New research finds promising treatment for hepatitis
C
ScienceDaily, Potential new class of
drugs to combat Hepatitis C identified
EurekAlert, Potential new class of drugs to combat Hepatitis C
identified
The
Independent (UK), New research finds promising treatment for hepatitis
C
Yahoo News, Team finds potential path for Hepatitis C
drugs
MSN Health, New treatment eyed for Hepatitis C
Health Day News, New treatment eyed for Hepatitis
C
eScience News, Potential new class of drugs to combat hepatitis C
identified by Stanford scientists
Inside
Stanford Medicine, Potential new class of drugs to combat Hepatitis C identified by
scientists, (Stanford University Cover)
BusinessWire, Potential new class of drugs to combat Hepatitis C
identified by Stanford scientists,
Sharp,
New Treatment
Eyed for Hepatitis,
the
Malay Mail, Scientists close in on hepatitis C vaccine
Topnews, Potential New Path for
Hepatitis C Medicines Discovered by Scientists
San
Francisco Business Times, Eiger IDs new class of hep C
inhibitors
eBioNews,
Potential New
Class of Drugs to Combat Hepatitis C Identified
My paper on the mechanism of
an antiviral peptide's mode of action is featured in ACS Chemical Biology
in December, 2009.
My paper on combined QCM-D and reflectometry
measurements to understand biomacromolecular interactions is featured in
Analytical Chemistry in May, 2009.
Dr. Kanazawa and I presented a
review article on QCM-D principles and biological applications in the Journal
of Sensors in April, 2009.
My paper on liver tissue engineering was
featured on the cover of Biomedical Materials in February, 2009.
Featured in Biomedical Materials in February,
2009.
Featured in Analytical Chemistry in May, 2009.
Science Translational Medicine: Three-dimensional rendering
of vesicle aggregation induced by an amphipathic, alpha helical peptide derived
from the hepatitis C virus NS4B protein, as imaged by atomic force
microscopy. light brown corresponds to vesicle aggregates.
Other updates
Sep. 10: "Daze with InfollutionZERO" a live graffiti performance
with the theme of infollutionZERO at the Korean National Science Museum was very
successful. Please check out the press coverage of this event here.
Oct.
10: http://www.infollutionzero.org/is launched! Please check out
the site. And join the infollutionZERO movement to clean the digital world for
our children.
Jul. 10: Josh Jackman joined the HST doctoral program @
MIT/Harvard. Congratulations Josh!
Mar.10: Josh Jackman's paper on the
binding interaction of secretory phospholipase A2 was featured in
Langmuir. Congratulations Josh!
Sep. 09: Wonjae Lee's paper on drug
release profile targeting was featured in Biomaterials in September, 2009.
Congratulations Wonjae!
Jun. 09: Wonjae Lee has earned his Ph.D. in
Mechanical Engineering from Stanford University. Congratulations
Wonjae!
Apr. 09: Sae-Moon Yoon's paper on QCM impedance spectra analysis
is featured in the Journal of Sensors in April, 2009. Congratulations
Sae-Moon!